SCHEMBL25968148

SCHEMBL25968148

CCOC(=O)C(C)(C)Cc1cc2cc(C)ccc2n1Cc1ccc(Cl)cc1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALOX5AP P20292 3/20 0.47
NOD2 Q9HC29 1/20 0.43
NOD1 Q9Y239 1/20 0.43
KDM4E B2RXH2 2/20 0.42
MAPT P10636 2/20 0.42
TDP1 Q9NUW8 2/20 0.42
MAPK1 P28482 1/20 0.42
NPSR1 Q6W5P4 1/20 0.42
PTGES2 Q9H7Z7 6/20 0.41
CYP1A2 P05177 1/20 0.41
CYP3A4 P08684 1/20 0.41
CYP2C9 P11712 1/20 0.41
HPGD P15428 1/20 0.41
TSHR P16473 1/20 0.41
CYP2C19 P33261 1/20 0.41
HIF1A Q16665 1/20 0.41
HSD17B10 Q99714 1/20 0.41
CCR2 P41597 3/20 0.41
MEN1 O00255 1/20 0.41
HTT P42858 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23270808 0.91 ALOX5AP (0.44) ALOX5APKDM4EMAPTTDP1MAPK1
SCHEMBL30181540 0.91 ALOX5AP (0.44) ALOX5APKDM4EMAPTTDP1MAPK1
SCHEMBL23270786 0.88 PTGES2 (0.53) ALOX5APKDM4EMAPTTDP1MAPK1
SCHEMBL23270840 0.84 ALOX5AP (0.54) ALOX5APCYP3A4CYP2C9MEN1KMT2A
SCHEMBL3103170 0.83 TBXA2R (0.48) ALOX5APNOD2KDM4EMAPTTDP1
SCHEMBL3088456 0.82 TBXA2R (0.48) ALOX5APNOD2KDM4EMAPTTDP1
SCHEMBL3094540 0.81 TBXA2R (0.46) ALOX5APNOD2KDM4EMAPTTDP1
SCHEMBL8561922 0.80 PTGES2 (0.49) ALOX5APPTGES2CCR2TBXA2RPTGS2
SCHEMBL9403254 0.79 CCR2 (0.53) ALOX5APMAPTMAPK1PTGES2CYP1A2
SCHEMBL25968196 0.76 PTGES2 (0.67) ALOX5APKDM4EMAPTTDP1MAPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11718614-B2 Compounds and methods for treatment of hedgehog pathway associated conditions SUZHOU MEDNES PHARMA TECH CO., LTD. (CN) 2023-08-08 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11718614-B2 Compounds and methods for treatment of hedgehog pathway associated conditions SHH, GLI1, SMO ALOX5AP 3783/4885NOD2 4337/4885NOD1 4414/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.